Latest News - Kala Pharmaceuticals

Thursday, July 20, 2017 | Earnings & Financials, Kala Pharmaceuticals

Kala Pharmaceuticals Announces Pricing of Initial Public Offering

Kala Pharmaceuticals announced that is has priced its initial public offering of 6,000,000 shares of its common stock at a public offering price of $15 per share, for aggregate gross proceeds of appro…

Read the full story

Monday, May 01, 2017 | Clinical Trials, Kala Pharmaceuticals

Kala Pharmaceuticals Announces Positive Results from Confirmatory Phase 3 Trial of KPI-121 1% Following Cataract Surgery

Kala Pharmaceuticals announced positive topline results from its confirmatory phase 3 trial of KPI-121 1% for the treatment of inflammation and pain in patients who have undergone cataract surgery. KP…

Read the full story